Probably Genetic: Funding, Investors & Team (Oct 2026)
Probably Genetic offers a solution for undiagnosed individuals suffering from rare diseases to quickly obtain answers to their symptoms. It is estimated that there are more than 400 million people globally with rare diseases, surpassing the combined number of cancer and HIV patients. Among these individuals, half remain undiagnosed, with children comprising a significant portion. Typically, it takes an average of 5-7 years for these patients to receive a diagnosis, but our system can provide answers within weeks. Our advanced Symptom Checker, available online, utilizes cutting-edge machine learning models to identify rare disease patients. They are then offered testing through our direct-to-consumer genetic testing service, enabling them to access potentially life-saving treatments and connect with advocacy communities. Additionally, we collaborate with pharmaceutical developers to offer sponsored testing programs, ensuring that patients can undergo genetic testing at minimal or no cost.
Probably Genetic has raised $10.7M across 1 funding round on record, the most recent an undisclosed round of $10.7M announced in Nov 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Probably Genetic Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Probably Genetic Funding Rounds
Probably Genetic Founders and Leadership Team
Contact details for the Probably Genetic team: 1 of 1 has an email address on file.
Start 14-day free trial →Probably Genetic Funding Compared to Other Biotechnology Startups
Probably Genetic's latest round of $10.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Probably Genetic in Biotechnology and Karlsruhe
Companies Similar to Probably Genetic
Artcline is a biotech company that creates diagnostic and therapeutic techniques for critical care medicine.
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
Probably Genetic Funding FAQs
What does Probably Genetic do?
Probably Genetic offers a solution for undiagnosed individuals suffering from rare diseases to quickly obtain answers to their symptoms. It is estimated that there are more than 400 million people globally with rare diseases, surpassing the combined number of cancer and HIV patients. Among these individuals, half remain undiagnosed, with children comprising a significant portion. Typically, it takes an average of 5-7 years for these patients to receive a diagnosis, but our system can provide answers within weeks. Our advanced Symptom Checker, available online, utilizes cutting-edge machine learning models to identify rare disease patients. They are then offered testing through our direct-to-consumer genetic testing service, enabling them to access potentially life-saving treatments and connect with advocacy communities. Additionally, we collaborate with pharmaceutical developers to offer sponsored testing programs, ensuring that patients can undergo genetic testing at minimal or no cost.
How much funding has Probably Genetic raised?
Probably Genetic has raised $10.7M across 1 round on record. The most recent is an undisclosed round of $10.7M announced in Nov 2023.
When did Probably Genetic last raise funding?
Probably Genetic's most recent funding round on record is an undisclosed round of $10.7M, announced in Nov 2023.
Who is the CEO of Probably Genetic?
Lukas Lange is listed as CEO at Probably Genetic.
Where is Probably Genetic headquartered?
Probably Genetic is based in Karlsruhe, Baden-Wurttemberg, Germany.
How many employees does Probably Genetic have?
Probably Genetic is in the 11-50 employee band.
How does Probably Genetic's funding compare to other Biotechnology startups?
Probably Genetic's latest round of $10.7M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Probably Genetic Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Probably Genetic is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.